Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

Specimen Handling 199 Magnetic Resonance Spectroscopy 154 Biopsy 120 pembrolizumab 89 Carboplatin 88 Cisplatin 78 Cyclophosphamide 75 Nivolumab 73 Paclitaxel 69 Radiotherapy 50 Gemcitabine 48 durvalumab 43 Bevacizumab 42 Doxorubicin 39 Fluorouracil 37 Dexamethasone 37 venetoclax 34 Capecitabine 34 olaparib 32 Etoposide 32 Rituximab 31 Radiation 31 Oxaliplatin 31 Lenalidomide 31 atezolizumab 29 Taxes 29 Pemetrexed 29 Injections 29 Docetaxel 29 fludarabine 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × famitinib × 30 days × Clear all

NCT05582499 2026-05-28

FASCINATE-N

Fudan University

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡